top of page

Managing Corporate Risks of the COVID-19 Pandemic:

A Business Continuity Planning and Recovery
Webinar Series for the High-Tech Sector

Coronavirus Banner - Main Page.jpg
Background

On March 11, the World Health Organization (WHO) declared COVID-19 a global pandemic.  As of  August 31, COVID-19 has infected more than 25 million individuals and killed over 844,000 worldwide.

Due to the highly interconnected nature of high-tech products and services as well as the complex extended value webs that serve these markets, the global high-technology sector seems to be particularly vulnerable to these non-market disease risks.

During times of uncertainty, scientific, technical and evidence-based knowledge can help companies in the high-tech sector understand, manage, and mitigate non-market risks. 

Webinar Introduction

To provide reliable information, Vichara Partners hosted a series of webinars focused on managing corporate risks of the global Coronavirus/COVID-19 pandemic from the perspective of the high-technology sector. To learn if you are part of our target audience, please click here.

 

To bring you the best information available, we drew on experts from a wide range of fields from epidemiologists, physicians, and public health experts to industry experts, business continuity specialists, risk management professionals, economists and supply chain managers.

Topics Covered

The webinars focused on three main content areas:

  • Understanding the Disease – The first two webinars focused on virus pathology, infectious agent transmission, clinical disease impacts, treatment, and vaccines, as well as the broader impacts of the disease to populations, economies, and society.

  • Business Continuity Planning and Recovery for Corporate Risk Managers – Four of the webinars focused on disease risks and impacts to employees, facilities, and supply chains. Approaches to mitigate these risks along with decision-making guidance will be shared.

  • Impacts of COVID-19 on High-Tech Markets – One of the webinars focused on disease impacts to segments of the extended supply chains for materials markets.

Recordings of the live webcasts are available. 

bottom of page